Literature DB >> 21558985

Investigation of systemic and mesenteric inflammatory signaling and gut-derived endothelial toxicity in patients undergoing high-risk abdominal aortic surgery.

Leigh Willoughby1, Paul Dark, Geoffrey Warhurst.   

Abstract

Evidence from animal models of trauma and hemorrhage has suggested that the gut plays an active role in the pathogenesis of systemic inflammatory responses and multiple organ dysfunction syndrome. The aim of the present study was to seek evidence for gut-derived signals in man in a group of eight patients undergoing elective abdominal aortic reconstruction, a procedure that is associated with sterile tissue injury, controlled colonic ischemia as a consequence of aortic cross-clamping, and a significant risk of developing systemic inflammation and multiple organ dysfunction syndrome. Despite the presence of a marked systemic inflammatory response (IL-6, IL-18, monocyte chemoattractant protein 1, and IL-8) and a gut-derived inflammatory signal (IL-6), we could find no evidence that gut-derived pathogen DNA was present in the central or mesenteric circulation, and we could find no evidence that either central or mesenteric plasma samples could induce apoptotic or necrotic cell death in human umbilical vein endothelial cells in vitro. Similarly, we could find no evidence of adhesion molecule upregulation in the endothelial monolayers exposed to central or mesenteric plasma sampled at any time point during surgery. There was, however, evidence of an increase in the expression of RAGE (receptor for advanced glycation end products) by endothelial cells following exposure to mesenteric venous, but not central, plasma sampled during maximum ischemia. In conclusion, during sterile tissue injury and controlled colonic ischemia-reperfusion in man, there is a marked systemic proinflammatory response, which is in part gut derived, in the absence of evidence for the presence of toxic endothelial factors or gut-derived microorganisms in the central or mesenteric circulations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558985     DOI: 10.1097/SHK.0b013e3182205bbd

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  3 in total

1.  R-spondin3 prevents mesenteric ischemia/reperfusion-induced tissue damage by tightening endothelium and preventing vascular leakage.

Authors:  Lakshmi Kannan; Katalin Kis-Toth; Kazuhisa Yoshiya; To-Ha Thai; Seema Sehrawat; Tanya N Mayadas; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-13       Impact factor: 11.205

2.  Emergency abdominal aortic aneurysm repair in a patient with failing heart: axillofemoral bypass using a centrifugal pump combined with levosimendan for inotropic support.

Authors:  Pavel Michalek; Pavel Sebesta; Michael Stern
Journal:  Case Rep Vasc Med       Date:  2011-12-18

3.  Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn's disease.

Authors:  Francesca Aparecida Ramos da Silva; Lívia Bitencourt Pascoal; Isabella Dotti; Maria de Lourdes Setsuko Ayrizono; Daniel Aguilar; Bruno Lima Rodrigues; Montserrat Arroyes; Elena Ferrer-Picon; Marciane Milanski; Lício Augusto Velloso; João José Fagundes; Azucena Salas; Raquel Franco Leal
Journal:  J Transl Med       Date:  2020-01-30       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.